All lanes : Anti-SULT1A1 antibody [9B7] (ab124011) at 1/500 dilutionLane 1 : HEK293T cells transfected with pCMV6-ENTRY control cDNALane 2 : HEK293T cells transfected with pCMV6-ENTRY SULT1A1 cDNALysates/proteins at 5 µg per lane.
All lanes : Anti-SULT1A1 antibody [9B7] (ab124011) at 1/500 dilutionLane 1 : HepG2 cell line lysateLane 2 : HeLa cell line lysateLane 3 : HT29 cell line lysateLane 4 : A549 cell line lysateLane 5 : COS7 cell line lysateLane 6 : Jurkat cell line lysateLane 7 : MDCK cell line lysateLane 8 : PC12 cell line lysateLane 9 : MCF7 cell line lysateLysates/proteins at 35 µg per lane.
ab124011, at 1/150, staining SULT1A1 in paraffin embedded Human prostate by Immunohistochemistry.
ab124011, at 1/150, staining SULT1A1 in paraffin embedded Human prostate carcinoma by Immunohistochemistry.
ab124011, at 1/150, staining SULT1A1 in paraffin embedded Human bladder by Immunohistochemistry.
ab124011, at 1/150, staining SULT1A1 in paraffin embedded Human bladder carcinoma by Immunohistochemistry.
ab124011, at 1/100, immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SULT1A1.
HEK293T cells transfected with either SULT1A1 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by ab124011, at 1/100, and then analyzed by flow cytometry.
Flow cytometric analysis of Jurkat cells, using ab124011, at 1/100, (Red) compared to a nonspecific negative control antibody (Blue).